Estimation of safe dietary intake levels of acrylamide for humans

Food and Chemical Toxicology

Volumn 48, Issue 2, 2010, Pages 658-667

  Tardiff, Robert G ^a   Gargas, Michael L ^a   Kirman, Christopher R ^a   Leigh Carson, M ^a   Sweeney, Lisa M ^a  

^a The Sapphire Group Inc   (United States)

Author keywords

Acrylamide; Cancer; Dietary intake; Food safety; Glycidamide; Neurotoxicity

Indexed keywords

ACRYLAMIDE; DRINKING WATER; GLYCIDAMIDE;

AREA UNDER THE CURVE; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DIETARY INTAKE; DOSE RESPONSE; EPIGENETICS; FEMALE; GENOTOXICITY; HUMAN; HUMAN EXPERIMENT; MALE; METABOLITE; NEUROTOXICITY; NONHUMAN; RAT; SAFETY; TOXICOKINETICS;

ACRYLAMIDE; ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; CARCINOGENS; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; EPOXY COMPOUNDS; FEMALE; FOOD CONTAMINATION; HUMANS; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NEUROTOXINS; RATS; RISK ASSESSMENT;

RATTUS;

EID: 74649083462     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.11.048     Document Type: Article

References (93)

1. Agrawal A.K., Seth P.K., Squibb R.E., Tilson H.A., Uphouse L.L., and Bondy S.C. Neurotransmitter receptors in brain regions of acrylamide-treated rats. I: Effects of a single exposure to acrylamide. Pharmacol. Biochem. Behav. 14 (1981) 527-531
2. Asano N., Torous D.K., Tometsko C.R., Dertinger S.D., Morita T., and Hayashi M. Practical threshold for micronucleated reticulocyte induction observed for low doses of mitomycin C, Ara-C and colchicine. Mutagenesis 21 (2006) 15-20
3. Barlow S., Renwick A.G., Kleiner J., Bridges J.W., Busk L., Dybing E., Edler L., Eisenbrand G., Fink-Gremmels J., Knaap A., Kroes R., Liem D., Muller D.J., Page S., Rolland V., Schlatter J., Tritscher A., Tueting W., and Wurtzen G. Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI Europe. Food Chem. Toxicol. 44 (2006) 1636-1650
4. Baum M., Loeppky R.N., Thielen S., and Eisenbrand G. Genotoxicity of glycidamide in comparison to 3-N-nitroso-oxazolidin-2-one. J. Agric. Food Chem. 56 (2008) 5989-5993
5. Bowyer J.F., Latendresse J.R., Delongchamp R.R., Muskhelishvili L., Warbritton A.R., Thomas M., Tareke E., McDaniel L.P., and Doerge D.R. The effects of subchronic acrylamide exposure on gene expression, neurochemistry, hormones, and histopathology in the hypothalamus-pituitary-thyroid axis of male Fischer 344 rats. Toxicol. Appl. Pharmacol. 230 (2008) 208-215 (Erratum in: Toxicol. Appl. Pharmacol. 232, 498)
6. Calleman C.J., Wu Y., He F., Tian G., Bergmark E., Zhang S., Deng H., Wang Y., Crofton K.M., Fennell T., et al. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol. Appl. Pharmacol. 126 (1994) 361-371
7. Carere A. Genotoxicity and carcinogenicity of acrylamide: a critical review. Ann. Ist. Super. Sanita 42 (2006) 144-155
8. Carlson G.P., Fossa A.A., Morse M.A., and Weaver P.M. Binding and distribution studies in the SENCAR mouse of compounds demonstrating a route-dependent tumorigenic effect. Environ. Health Perspect. 68 (1986) 53-60
9. Carlson G.P., and Weaver P.M. Distribution and binding of [14C] acrylamide to macromolecules in SENCAR and BALB/c mice following oral and topical administration. Toxicol. Appl. Pharmacol. 79 (1985) 307-313
10. Collins J.J., Swaen G.M., Marsh G.M., Utidjian H.M., Caporossi J.C., and Lucas L.J. Mortality patterns among workers exposed to acrylamide. J. Occup. Med. 31 (1989) 614-617
11. DiNovi, M., 2006. The 2006 Exposure Assessment for Acrylamide. [Powerpoint Presentation]. US Food and Drug Administration.
12. Doak S.H., Jenkins G.J., Johnson G.E., Quick E., Parry E.M., and Parry J.M. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 67 (2007) 3904-3911
13. Dourson M., Hertzberg R., Allen B., Haber L., Parker A., Kroner O., Maier A., and Kohrman M. Evidence-based dose response assessment for thyroid tumorigenesis from acrylamide. Regul. Toxicol. Pharmacol. 52 (2008) 264-289
14. Dybing E., and Sanner T. Risk assessment of acrylamide in foods. Toxicol. Sci. 75 (2003) 7-15
15. Erdreich L.S., and Friedman M.A. Epidemiologic evidence for assessing the carcinogenicity of acrylamide. Regul. Toxicol. Pharmacol. 39 (2004) 150-157
16. European Food Safety Authority (EFSA), 2009. Results on the Monitoring of Acrylamide Levels in Food. EFSA Scientific Report, vol. 285, pp. 1-26.
17. Farris G.M., Wong V.A., Wong B.A., Janszen D.B., and Shah R.S. Benzene-induced micronuclei in erythrocytes: an inhalation concentration-response study in B6C3F1 mice. Mutagenesis 11 (1996) 455-462
18. Favor J. The mutagenic activity of ethylnitrosourea at low doses in spermatogonia of the mouse as assessed by the specific-locus test. Mutat. Res. 405 (1998) 221-226
19. Friedman M.A., Dulak L.H., and Stedham M.A. A lifetime oncogenicity study in rats with acrylamide. Fundam. Appl. Toxicol. 27 (1995) 95-105
20. Friedman M.A., Zeiger E., Marroni D.E., and Sickles D.W. Inhibition of rat testicular nuclear kinesins (krp2; KIFC5A) by acrylamide as a basis for establishing a genotoxicity threshold. J. Agric. Food Chem. 56 (2008) 6024-6030
21. Galesa K., Bren U., Kranjc A., and Mavri J. Carcinogenicity of acrylamide: a computational study. J. Agric. Food Chem. 56 (2008) 8720-8727
22. Gargas M.L., Kirman C.K., Sweeney L.M., and Tardiff R.G. Acrylamide: consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion. Food Chem. Toxicol. 49 (2009) 760-768
23. Gilbert S.G., and Maurissen J.P. Assessment of the effects of acrylamide, methylmercury, and 2,5-hexanedione on motor functions in mice. J. Toxicol. Environ. Health 10 (1982) 31-41
24. Guttenplan J.B. Mutagenesis by N-nitroso compounds: relationships to DNA adducts, DNA repair, and mutational efficiencies. Mutat. Res. 233 (1990) 177-187
25. Haber L.T., Maier A., Kroner O.L., and Kohrman M.J. Evaluation of human relevance and mode of action for tunica vaginalis mesotheliomas resulting from oral exposure to acrylamide. Regul. Toxicol. Pharmacol. 53 (2009) 134-149
26. Hagmar L., Tornqvist M., Nordander C., Rosen I., Bruze M., Kautiainen A., Magnusson A.L., Malmberg B., Aprea P., Granath F., and Axmon A. Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scand. J. Work Environ. Health 27 (2001) 219-226
27. Hashimoto K., Sakamoto J., and Tanii H. Neurotoxicity of acrylamide and related compounds and their effects on male gonads in mice. Arch. Toxicol. 47 (1981) 179-189
28. Health Canada, 1994. Human Health Risk Assessment for Priority Substances. Canadian Environmental Protection Act, Ontario.
29. Hogervorst J.G., Schouten L.J., Konings E.J., Goldbohm R.A., and van den Brandt P.A. Dietary acrylamide intake is not associated with gastrointestinal cancer risk. J. Nutr. 138 (2008) 2229-2236
30. Hogervorst J.G., Schouten L.J., Konings E.J., Goldbohm R.A., and van den Brandt P.A. Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer. Am. J. Clin. Nutr. 87 (2008) 1428-1438
31. Hogervorst J.G., Schouten L.J., Konings E.J., Goldbohm R.A., and van den Brandt P.A. A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 2304-2313
32. Hogervorst J.G., Schouten L.J., Konings E.J., Goldbohm R.A., and van den Brandt P.A. Dietary acrylamide intake and brain cancer risk. Cancer Epidemiol. Biomarkers Prev. 18 (2009) 1663-1666
33. Hogervorst J.G., Schouten L.J., Konings E.J., Goldbohm R.A., and van den Brandt P.A. Lung cancer risk in relation to dietary acrylamide intake. J. Natl. Cancer Inst. 101 (2009) 651-662
34. Johnson K.A., Gorzinski S.J., Bodner K.M., Campbell R.A., Wolf C.H., Friedman M.A., and Mast R.W. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol. 85 (1986) 154-168
35. Johnson G.E., Doak S.H., Griffiths S.M., Quick E.L., Skibinski D.O., Zair Z.M., and Jenkins G.J. Non-linear dose-response of DNA-reactive genotoxins: recommendations for data analysis. Mutat. Res. 678 (2009) 95-100
36. Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2002. Health Implications of Acrylamide in Food. World Health Organization.
37. Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2005. Joint FAO/WHO Expert Committee on Food Additives Sixty-fourth Meeting, Rome, 8-17 February 2005. World Health Organization.
38. Keefe, R.T., 1991. 28-Day Subchronic Toxicity Study in Rats. Final report. Exxon Biomedical Sciences, Inc.
39. Larsson S.C., Akesson A., and Wolk A. Long-term dietary acrylamide intake and risk of epithelial ovarian cancer in a prospective cohort of Swedish women. Cancer Epidemiol. Biomarkers Prev. 18 (2009) 994-997
40. Larsson S.C., Akesson A., and Wolk A. Long-term dietary acrylamide intake and breast cancer risk in a prospective cohort of Swedish women. Am. J. Epidemiol. 169 (2009) 376-381
41. Larsson S.C., Hakansson N., Akesson A., and Wolk A. Long-term dietary acrylamide intake and risk of endometrial cancer in a prospective cohort of Swedish women. Int. J. Cancer 124 (2009) 1196-1199
42. Larsson S.C., Akesson A., and Wolk A. Dietary acrylamide intake and prostate cancer in a prospective cohort of Swedish men. Cancer Epidemiol. Biomarkers Prev. 18 (2009) 1939-1941
43. Larsson S.C., Kesson A., Bergkvist L., and Wolk A. Dietary acrylamide intake and risk of colorectal cancer in a prospective cohort of men. Eur. J. Cancer 45 (2009) 513-516
44. LoPachin R.M. The changing view of acrylamide neurotoxicity. Neurotoxicology 25 (2004) 617-630
45. Lunds University, 2007. The HEATOX Project: Heat-generated Food Toxicants - Identification, Characterisation and Risk Minimisation. Project 506820. Scandinavia.
46. Maekawa A., Ogiu T., Matsuoka C., Onodera H., Furuta K., Kurokawa Y., Takahashi M., Kokubo T., Tanigawa H., and Hayashi Y. Carcinogenicity of low doses of N-ethyl-N-nitrosourea in F344 rats; a dose-response study. Gann 75 (1984) 117-125
47. Marsh G.M., Lucas L.J., Youk A.O., and Schall L.C. Mortality patterns among workers exposed to acrylamide: 1994 follow up. Occup. Environ. Med. 56 (1999) 181-190
48. Marsh G.M., Youk A.O., Buchanich J.M., Kant I.J., and Swaen G. Mortality patterns among workers exposed to acrylamide: updated follow up. J. Occup. Environ. Med. 49 (2007) 82-95
49. Martenson C.H., Odom A., Sheetz M.P., and Graham D.G. The effect of acrylamide and other sulfhydryl alkylators on the ability of dynein and kinesin to translocate microtubules in vitro. Toxicol. Appl. Pharmacol. 133 (1995) 73-81
50. Maurissen J.P., Weiss B., and Cox C. Vibration sensitivity recovery after a second course of acrylamide intoxication. Fundam. Appl. Toxicol. 15 (1990) 93-98
51. Maurissen J.P., Weiss B., and Davis H.T. Somatosensory thresholds in monkeys exposed to acrylamide. Toxicol. Appl. Pharmacol. 71 (1983) 266-279
52. Meek M.E., Bucher J.R., Cohen S.M., Dellarco V., Hill R.N., Lehmen-McKeeman L.D., Longfellow D.G., Pastoor T., Seed J., and Patton D.E. A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 33 (2003) 591-653
53. Mei N., Hu J., Churchwell M.I., Guo L., Moore M.M., Doerge D.R., and Chen T. Genotoxic effects of acrylamide and glycidamide in mouse lymphoma cells. Food Chem. Toxicol. 46 (2008) 628-636
54. Moore M.M., Amtower A., Doerr C., Brock K.H., and Dearfield K.L. Mutagenicity and clastogenicity of acrylamide in L5178Y mouse lymphoma cells. Environ. Mutagen. 9 (1987) 261-267
55. Mucci L.A., Sandin S., Magnusson C., and Weiderpass E. Acrylamide intake and breast cancer risk in Swedish women. JAMA 293 (2005) 1326-1327
56. Mucci L.A., Dickman P.W., Steineck G., Adami H.O., and Augustsson K. Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br. J. Cancer 88 (2003) 84-89
57. Mucci L.A., Lindblad P., Steineck G., and Adami H.O. Dietary acrylamide and risk of renal cell cancer. Int. J. Cancer 109 (2004) 774-776
58. Mucci L.A., Adami H.O., and Wolk A. Prospective study of dietary acrylamide and risk of colorectal cancer among women. Int. J. Cancer 118 (2006) 169-173
59. Mucci L.A., and Wilson K.M. Acrylamide intake through diet and human cancer risk. J. Agric. Food Chem. 56 (2008) 6013-6019
60. Mucci L.A., and Adami H.O. The plight of the potato: is dietary acrylamide a risk factor for human cancer. J. Natl. Cancer Inst. 101 (2009) 618-621
61. Muri S.D., Schlatter J.R., and Bruschweiler B.J. The benchmark dose approach in food risk assessment: is it applicable and worthwhile?. Food. Chem. Toxicol. 47 (2009) 2906-2925
62. National Research Council (NRC), 1983. Risk Assessment in the Federal Government: Managing the Process. National Academy Press, Washington, DC.
63. Office of Environmental Health Hazard Assessment (OEHHA), 2006. No Significant Risk Level (NSRL) for the Proposition 65 Carcinogen: Acrylamide. California Environmental Protection Agency.
64. Paulsson B., Warholm M., Rannug A., and Tornqvist M. In vitro studies of the influence of certain enzymes on the detoxification of acrylamide and glycidamide in blood. Adv. Exp. Med. Biol. 561 (2005) 127-133
65. Paulsson B., Rannug A., Henderson A.P., Golding B.T., Tornqvist M., and Warholm M. In vitro studies of the influence of glutathione transferases and epoxide hydrolase on the detoxification of acrylamide and glycidamide in blood. Mutat. Res. 580 (2005) 53-59
66. Parry J.M., Jenkins G.J., Haddad F., Bourner R., and Parry E.M. In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds. Mutat. Res. 464 (2000) 53-63
67. Pelucchi C., Franceschi S., Levi F., Trichopoulos D., Bosetti C., Negri E., and La Vecchia C. Fried potatoes and human cancer. Int. J. Cancer 105 (2003) 558-560
68. Pelucchi C., Galeone C., Levi F., Negri E., Franceschi S., Talamini R., Bosetti C., Giacosa A., and LaVecchia C. Dietary acrylamide and human cancer. Int. J. Cancer 118 (2006) 467-471
69. Pelucchi C., Galeone C., Dal Maso L., Talamini R., Montella M., Ramazzotti V., Negri E., Franceschi S., and La Vecchia C. Dietary acrylamide and renal cell cancer. Int. J. Cancer 120 (2007) 1376-1377
70. Pelucchi C., Galeone C., Dal Maso L., Talamini R., Montella M., Ramazzotti V., Negri E., Franceschi S., and La Vecchia C. Dietary acrylamide and renal cell cancer. Int. J. Cancer 120 (2007) 1376-1377
71. Phelps K.K., and Walker R.A. N-ethylmaleimide inhibits Ncd motor function by modification of a cysteine in the stalk domain. Biochemistry 38 (1999) 10750-10757
72. Post E.J., and McLeod J.G. Acrylamide autonomic neuropathy in the cat. Part 1. Neurophysiological and histological studies. J. Neurol. Sci. 33 (1977) 353-374
73. Renwick G.A., Leblanc J.-C., and Setzer R.W. Application of the margin of exposure (MoE) approach to substances in food that are genotoxic and carcinogenic. Example: leucomalachite green. Food Chem. Toxicol. 48 (2010) S75-S80
74. Renwick G.A., Leblanc J.-C., and Setzer R.W. Application of the margin of exposure (MoE) approach to substances in food that are genotoxic and carcinogenic. Example: 1-methylcyclopropene and its impurities (1-chloro-2-methylpropene and 3-chloro-2-methylpropene). Food Chem. Toxicol. 48 (2010) S81-S88
75. Rozman K. Influence of dynamics, kinetics, and exposure on toxicity in the lung. In: Gardner D.E. (Ed). Toxicology of the Lung. fourth ed. (2006), Taylor and Francis, Boca Raton 195-230
76. Satchell P.M., and McLeod J.G. Megaoesophagus due to acrylamide neuropathy. J. Neurol. Neurosurg. Psychiatry 44 (1981) 906-913
77. Schulz M.R., Hertz-Picciotto I., van Wijngaarden E., Hernandez J.C., and Ball L.M. Dose-response relation between acrylamide and pancreatic cancer. Occup. Environ. Med. 58 (2001) 609
78. Shipp A., Lawrence G., Gentry R., McDonald T., Bartow H., Bounds J., Macdonald N., Clewell M., Allen B., and Van Landingham C. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects. Crit. Rev. Toxicol. 36 (2006) 481-608
79. Sickles D.W., Brady S.T., Testino A., Friedman M.A., and Wrenn R.W. Direct effect of the neurotoxicant acrylamide on kinesin-based microtubule motility. J. Neurosci. Res. 46 (1996) 7-17
80. Swaen G.M., Haidar S., Burns C.J., Bodner K., Parsons T., Collins J.J., and Baase C. Mortality study update of acrylamide workers. Occup. Environ. Med. 64 (2007) 396-401
81. Sweeney, L.M., Kirman, C.R., Gargas, M.L., Carson, M.L., Tardiff, R.G., 2010. Development of a physiologically-based toxicokinetic model of acrylamide and glycidamide in rats and humans. Food. Chem. Toxicol., in press.
82. Swenberg J.A., Fryar-Tita E., Jeong Y.C., Boysen G., Starr T., Walker V.E., and Albertini R.J. Biomarkers in toxicology and risk assessment: informing critical dose-response relationships. Chem. Res. Toxicol. 21 (2008) 253-265
83. Tareke E., Rydberg P., Karlsson P., Eriksson S., and Törnqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J. Agric. Food Chem. 50 (2002) 4998-5006
84. US Environmental Protection Agency (USEPA), 1991. Integrated Risk Information System: Acrylamide Summary.
85. US Environmental Protection Agency (USEPA). 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Research Triangle Park, NC. EPA/600/8-90/066F.
86. US Environmental Protection Agency (USEPA), 2002. A Review of the Reference Dose and Reference Concentration Process. Risk Assessment Forum, Washington, DC. EPA/630/P-02/002F.
87. US Environmental Protection Agency (USEPA), 2005. Guidelines for Carcinogen Risk Assessment. Washington, DC. NCEA-F-0644.
88. Waddell W.J. Critique of dose response in carcinogenesis. Hum. Exp. Toxicol. 25 (2006) 413-436
89. Wilson K.M., Mucci L.A., Cho E., Hunter D.J., Chen W.Y., and Willett W.C. Dietary acrylamide intake and risk of premenopausal breast cancer. Am. J. Epidemiol. 169 (2009) 954-961
90. World Health Organization (WHO). Acrylamide. Environ. Health Criteria (1985) 49
91. World Health Organization (WHO), 2005. Chemical-specific adjustment factors for interspecies differences and human variability: guidance document for use of data in dose/concentration-response assessment. International Program on Chemical Safety.
92. World Health Organization (WHO), 2006. Guidelines for Drinking Water Quality, third ed. Geneva.
93. Zeiger E., Recio L., Fennell T., Haseman J.K., Snyder R.W., and Friedman M. Investigation of the low-dose response in the in vivo induction of micronuclei and adducts by acrylamide. Toxicol. Sci. 107 (2009) 247-257